Melisha Poken Email

Quality Assurance Manager . GESLabs

Current Roles

Employees:
34
Revenue:
$6.8M
About
GES is a specialist manufacturer of therapeutic cannabis products derived from medical-grade medical cannabis flowers designed for pharmaceutical applications. Our facility focuses on the extraction and purification of primary bulk cannabinoids, D9-THC, and CBD selected from GES network of high-quality cultivators. Though our extensive research and development programs we have developed proprietary chemo-type specific formulations of API designed to match the therapeutic aspects of medical cannabis. We offer a source-to-shelf private-label solution for cannabinoid inhalation cartridges and pharmacy syringe compound kits. See the website for more details. We manufacture all our products with pharmaceutical Good Manufacturing Practice (GMP) and have been produced with modernized pharmaceutical manufacturing technologies to ensure consistency and standardization. \n\nWe believe in harnessing nature's naturally readily abundant active therapies transformed with today’s scientific discoveries.
GESLabs Address

London, null
UK
GESLabs Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.